Therapeutic approaches for combating Pseudomonas aeruginosa infections

Microbes Infect. 2022 Jun;24(4):104950. doi: 10.1016/j.micinf.2022.104950. Epub 2022 Feb 6.

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen responsible for acute hospital-acquired infections. This review described various therapeutic approaches to treat infections caused by P. aeruginosa, including conventional therapy, novel antibiotic treatments and treatments other than antibiotics. Most of the developments are still in research that will provide novel treatment options in future.

Keywords: Novel antibiotics; Pseudomonas aeruginosa; Resistance mechanisms; Therapeutic treatments.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa

Substances

  • Anti-Bacterial Agents